Corcept CFO Atabak Mokari sells 79,000 shares worth $8.95 million
CORT•CFO exercises options and sells shares
- Corcept Therapeutics CFO Atabak Mokari exercised stock options for 80,000 shares at $23.06 on July 30, 2026.
- He sold 79,870 shares the same day in multiple trades priced at about $105.54 to $120.67.
- He held 16,130 shares of common stock following the transactions.
